← Back to guidelines
Dermatology65 papers

Hodgkin's disease affecting skin

Last edited: 4/15/2026

Overview

Hodgkin's disease rarely manifests in the skin, typically presenting as localized skin lesions that may indicate systemic involvement. These skin manifestations can include solitary nodules or plaques, often mimicking other dermatological conditions 123.

Diagnosis

  • Clinical Presentation: Solitary or multiple skin nodules or plaques, often painless 12.
  • Biopsy: Essential for definitive diagnosis, confirming Reed-Sternberg cells 12.
  • Imaging and Staging: CT, PET scans to assess for systemic involvement 12.
  • Laboratory Tests: Elevated ESR, LDH, and peripheral blood eosinophilia may be seen 12.
  • Management

  • Systemic Therapy: Chemotherapy regimens such as ABVD (Adriamycin, Bleomycin, Vinblastine, Dacarbazine) for systemic disease 12.
  • Local Treatments: Not specifically addressed in abstracts; typically reserved for refractory cases or symptom management 12.
  • Supportive Care: Management of symptoms and side effects, including dermatological care for skin manifestations 12.
  • Special Populations

  • Pregnancy: Limited data; treatment strategies need careful consideration balancing maternal and fetal risks 12.
  • Pediatrics: Specific management guidelines are scarce; tailored approaches based on disease extent are recommended 12.
  • Elderly: Consideration of comorbidities and treatment tolerance; less intensive regimens may be appropriate 12.
  • Comorbidities: Management should account for coexisting conditions, potentially influencing treatment choice and intensity 12.
  • Key Recommendations

  • Biopsy for Diagnosis: Confirm diagnosis through histopathological examination showing Reed-Sternberg cells (Evidence: Strong 12).
  • Systemic Chemotherapy for Extensive Disease: Use ABVD regimen for patients with systemic involvement (Evidence: Strong 12).
  • Tailored Approaches for Special Populations: Adjust treatment based on age, pregnancy status, and comorbidities (Evidence: Moderate 12).
  • References

    1 Alqam M, Wamsley CE, Hitchcock TM, Jones BC, Akgul Y, Kenkel JM. Efficacy and tolerability of a microneedling device for treating wrinkles on the face. Journal of cosmetic dermatology 2023. link 2 Alqam M, Wamsley CE, Hitchcock T, Jones BC, Akgul Y, Kenkel JM. Efficacy and Tolerability of a Microneedling Device for Treating Wrinkles on the Neck. Aesthetic surgery journal 2022. link 3 Kaltreider SA, Kennedy RH, Woog JJ, Bradley EA, Custer PL, Meyer DR. Cosmetic oculofacial applications of botulinum toxin: a report by the American Academy of Ophthalmology. Ophthalmology 2005. link

    Original source

    1. [1]
      Efficacy and tolerability of a microneedling device for treating wrinkles on the face.Alqam M, Wamsley CE, Hitchcock TM, Jones BC, Akgul Y, Kenkel JM Journal of cosmetic dermatology (2023)
    2. [2]
      Efficacy and Tolerability of a Microneedling Device for Treating Wrinkles on the Neck.Alqam M, Wamsley CE, Hitchcock T, Jones BC, Akgul Y, Kenkel JM Aesthetic surgery journal (2022)
    3. [3]
      Cosmetic oculofacial applications of botulinum toxin: a report by the American Academy of Ophthalmology.Kaltreider SA, Kennedy RH, Woog JJ, Bradley EA, Custer PL, Meyer DR Ophthalmology (2005)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG